Abstract
There is a need for new, safer, and more effective agents to treat cancer. Cytostatics that have transition metals at their core have attracted renewed interest from scientists. Researchers are attempting to use chemotherapeutics, such as cisplatin, in combination therapy (i.e., in order to enhance their effectiveness). Moreover, studies are being carried out to modify molecules, by developing them into multinuclear structures, linking different compounds to commonly used drugs, or encapsulating them in nanoparticles to improve pharmacokinetic parameters, and increase the selectivity of these drugs. Therefore, we attempted to organize recent drug findings that contain palladium and platinum atoms in their structures.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Spectroscopic inspection, DFT analysis, biological evaluation and molecular docking studies of new 2-(phenylamino)acetohydrazide hydrazone based- transition metal complexes;Inorganica Chimica Acta;2024-04
2. Advances in Breast Cancer Drug Discovery: A Review of Therapeutic Strategies and Studies Involving Photosensitizers, Caged Xanthones and Thiosemicarbazones Derivatives;Journal of the Brazilian Chemical Society;2024
3. KINETIC STUDY OF THE REACTION BETWEEN THE CYCLOPALLADATED COMPLEX [PdCl(C2 ,N-dmba)(tu)] (dmba = N,N-DIMETHYLBENZYLAMINE, tu = THIOUREA) AND L-CYSTEINE;Química Nova;2024
4. Anticancer behaviour of 2,2′-(pyridin-2-ylmethylene)bis(5,5-dimethylcyclohexane-1,3-dione)-based palladium(II) complex and its DNA, BSA binding propensity and DFT study;Journal of Inorganic Biochemistry;2024-01
5. Palladium (II) compounds containing oximes as promising antitumor agents for the treatment of osteosarcoma: An in vitro and in vivo comparative study with cisplatin;European Journal of Medicinal Chemistry;2024-01